Showing results (51-60 of 115) with videos related to
Sort By:
Pageof 12
Sensors (Basel, Switzerland)|December 9, 2023
Failure of Digital Device Performance in Monitoring Physical Exercise in a Pilot Study in Sedentary Persons with HIVMatteo Bonato, Federica Marmondi, Filippo Turrini, et al.Journal of Clinical Microbiology|November 8, 2003
Real-time PCR assay for clinical management of human immunodeficiency virus-infected patients with visceral leishmaniasisSimona Bossolasco, Giovanni Gaiera, Davide Olchini, et al.Annals of Neurology|March 3, 2004
Changing incidence of central nervous system diseases in the EuroSIDA cohortAntonella d'Arminio Monforte, Paola Cinque, Amanda Mocroft, et al.Medicine|October 25, 2022
Long-acting drugs: people's expectations and physicians' preparedness. Are we readying to manage it? An Italian surveyMarta Celesia, Vittoria Moscatt, Alessandra Tzannis, et al.The Journal of Infectious Diseases|March 17, 2023
Biotypes of Central Nervous System Complications in People With Human Immunodeficiency Virus: Virology, Immunology, and NeuropathologySarah B Joseph, Sara Gianella, Tricia H Burdo, et al.AIDS (London, England)|December 3, 2019
Defining cerebrospinal fluid HIV RNA escape: editorial review AIDSAlan Winston, Andrea Antinori, Paola Cinque, et al.Journal of Neuroimmunology|December 8, 2004
Expression of the urokinase plasminogen activator and its receptor in HIV-1-associated central nervous system diseaseNicolai Sidenius, Manuela Nebuloni, Stefania Sala, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 19, 2018
Diagnostic and Prognostic Value of JC Virus DNA in Plasma in Progressive Multifocal LeukoencephalopathyFrancesca Ferretti, Arabella Bestetti, Constantin T Yiannoutsos, et al.The Journal of Infectious Diseases|August 17, 2011
Central nervous system immune activation characterizes primary human immunodeficiency virus 1 infection even in participants with minimal cerebrospinal fluid viral burdenSerena Spudich, Magnus Gisslen, Lars Hagberg, et al.International Journal of Antimicrobial Agents|January 12, 2020
Retrospective study on the outcome of two-drug regimens based on dolutegravir plus one reverse transcriptase inhibitor in virologically-suppressed HIV-infected patientsNadia Galizzi, Andrea Poli, Laura Galli, et al.Pageof 12